Arrowstreet Capital
BEAT

Arrowstreet Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Arrowstreet Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-164,937
Closed -$1.66M – 1363
2014
Q1 		$1.66M Sell
164,937
-14,200
-8% -$131K 0.01% 699
2013
Q4 		$1.42M Buy
+179,137
New +$1.67M 0.01% 752

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Arrowstreet Capital's BEAT Position: Q2 2014 in Review

Arrowstreet Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2014, closing a stake of 164,937 shares — an estimated $1.66M sold.

Arrowstreet Capital first reported a position in BEAT in Q4 2013 and held it in 2 quarters. The position peaked at $1.66M in Q1 2014. 93 funds tracked by Wall St. Rank hold BEAT as of Q2 2014.

  • Arrowstreet Capital reported no remaining BioTelemetry, Inc. position as of Q2 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 164,937 BioTelemetry, Inc. shares in Q2 2014, an estimated $1.66M.
  • Arrowstreet Capital first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 2 quarters.
  • Arrowstreet Capital's BioTelemetry, Inc. position peaked at $1.66M in Q1 2014.
  • 93 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2014.

Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.